🧪 Hypotheses

combination 0.00

GLUT1-Mediated Carrier-Conjugate Delivery Strategy

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

The GLUT1-Mediated Carrier-Conjugate Delivery Strategy proposes that therapeutic antibody delivery to the CNS can be optimized by targeting the glucos...

combination 0.00

LDLR-Primed LRP1 Transcytosis with pH-Responsive Escape Strategy

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

This strategy combines targeted upregulation of LDLR expression in brain endothelial cells with engineered antibodies designed for LRP1-mediated trans...

combination 0.00

LDLR-Mediated Neurosteroid Precursor Delivery Strategy

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

The LDLR-Mediated Neurosteroid Precursor Delivery Strategy proposes utilizing the low-density lipoprotein receptor (LDLR) not for antibody transport, ...

unknown 0.66

Parthenolide reduces tonic ADORA2A signaling by lowering inflammatory extracellular adenosine tone

🧬 ADORA2A 🏥 neuropharmacology 📖 6🏛 1

✅ 0.74 ✨ 0.64 💥 0.66

NF-kB suppression in glia decreases ectonucleotidase and cytokine programs that sustain extracellular adenosine, indirectly reducing ADORA2A pathway o...

unknown 0.62

CX3CR1-Targeted HDAC3 Knockdown in Microglia via AAV9 Delivery

🧬 HDAC3 (class I histone deacetylase) 🏥 pharmacology 📖 0🏛 1

✅ 0.45 ✨ 0.60 💥 0.75

## Mechanistic Overview...

combination 0.58

FcRn Transport Bypass Strategy

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.70 ✨ 0.40 💥 0.80

## Mechanistic Overview...

unknown 0.57

Brain-Ester Prodrug Strategy for CNS-Selective HDAC6 Inhibition

🧬 HDAC6 (class IIb histone deacetylase) 🏥 pharmacology 📖 0🏛 1

✅ 0.38 ✨ 0.70 💥 0.68

## Mechanistic Overview...

therapeutic 0.55

MFSD2A-Targeted Lysophosphatidylcholine-SPM Conjugates as CNS-Penetrant Pro-Resolving Prodrugs

🧬 MFSD2A (SLC59A1) 🏥 neuropharmacology 📖 15🏛 1

✅ 0.35 ✨ 0.85 💥 0.72

## Mechanistic Overview...

unknown 0.53

CX3CR1-Targeted AntimiR-155 Oligonucleotides for Microglial Priming Reversal

🧬 MIR155 (microRNA-155) 🏥 pharmacology 📖 0🏛 1

✅ 0.30 ✨ 0.75 💥 0.60

## Mechanistic Overview...

combination 0.52

LRP1-Mediated Endosomal Escape Enhancement Strategy

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

The LRP1-Mediated Endosomal Escape Enhancement Strategy proposes that therapeutic antibody delivery to the CNS can be optimized by targeting the low-d...

unknown 0.51

Parthenolide perturbs adenosine transport or metabolism upstream of ADORA2A

🧬 ADORA2A 🏥 neuropharmacology 📖 1🏛 1

✅ 0.61 ✨ 0.67 💥 0.55

Covalent modulation of transporters or metabolic enzymes changes local receptor occupancy in a context-dependent manner.

combination 0.50

SIRT1-Mediated Epigenetic Restoration of MFSD2A Expression Re-enables SPM Precursor Transport in Aged BBB

🧬 MFSD2A / SIRT1 (deacetylase activator axis) 🏥 neuropharmacology 📖 12🏛 1

✅ 0.30 ✨ 0.65 💥 0.58

## Mechanistic Overview...

combination 0.50

LDLR-Targeted Anti-Inflammatory Antibody Delivery for Neuroinflammation Suppression

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

This hypothesis proposes engineering therapeutic antibodies with dual functionality: LDLR-binding domains for CNS penetration coupled to anti-inflamma...

unknown 0.48

Parthenolide enhances ADORA2A receptor internalization through direct sesquiterpene lactone-mediated cysteine modificati

🧬 ADORA2A 🏥 neuropharmacology 📖 6🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

Parthenolide directly targets ADORA2A receptors through its reactive sesquiterpene lactone moiety, which forms covalent Michael adducts with specific ...

unknown 0.44

Parthenolide changes ADORA2A coupling efficiency through membrane microdomain remodeling

🧬 ADORA2A 🏥 neuropharmacology 📖 0🏛 1

✅ 0.50 ✨ 0.76 💥 0.49

The scaffold alters receptor signaling efficacy without strong orthosteric affinity by modifying redox-sensitive lipid nanodomains.

combination 0.38

RAGE-Mediated Transcytotic Pump Enhancement Strategy

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

The RAGE-Mediated Transcytotic Pump Enhancement Strategy proposes that therapeutic antibody delivery to the CNS can be optimized by targeting the rece...

combination 0.38

LDLR-Mediated Reverse Cholesterol Transport Modulation for CNS Drug Delivery

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

The LDLR-Mediated Reverse Cholesterol Transport Modulation strategy proposes that CNS drug delivery can be enhanced by hijacking the LDLR-dependent re...

combination 0.38

LDLR-Primed LRP1 Transcytosis with Endosomal Liberation Strategy

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

This strategy combines LDLR upregulation-mediated cholesterol transport machinery priming with engineered endosomal escape mechanisms to achieve super...

combination 0.38

LDLR-Mediated Lipid Carrier Neurotherapeutic Delivery

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

## Mechanistic Overview...

combination 0.38

LDLR-Primed LRP1 Transcytosis with pH-Activated Endosomal Escape

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

This strategy combines LDLR upregulation in brain endothelial cells with engineered LRP1-targeting antibodies containing pH-responsive endosomal escap...

combination 0.38

LDLR-Mediated Neuroinflammation Modulation Strategy

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

The LDLR-Mediated Neuroinflammation Modulation Strategy proposes that direct pharmacological enhancement of LDLR expression and activity within brain ...